The decision to increase the gap between two doses of the Covishield vaccine was "transparent" and "based on scientific data". In a tweet health minister Dr Harshvardhan said, India has a robust mechanism to evaluate data. It is unfortunate that such an important issue is being politicised!"
Decision to increase the gap between administering 2 doses of #COVISHIELD has been taken in a transparent manner based on scientific data.
— Dr Harsh Vardhan (@drharshvardhan) June 16, 2021
India has a robust mechanism to evaluate data.
It's unfortunate that such an important issue is being politicised!https://t.co/YFYMLHi21L
He attached a statement from the government that extensively quoted Dr NK Arora, the chief of the National Technical Advisory Group on Immunisation (NTAGI), on the subject.In the statement Dr Arora was quoted citing a study by UK health regulator Public Health England that "showed vaccine efficacy varied between 65 per cent - 88 per cent when interval is 12 weeks.
#LargestVaccinationDrive
— Ministry of Health (@MoHFW_INDIA) June 15, 2021
NTAGI Chair Dr N K Arora: Decision regarding enhancing interval between two doses of #Covishield based on scientific evidence & taken in a transparent manner. There was no dissenting voice among the NTAGI members.@PMOIndia @drharshvardhan @PIB_India https://t.co/ANaOwkkSO7
Newsinc24 Team





Related Items
Bank credit growth accelerates to 16%, shows RBI data
Maharashtra to strengthen tribal and technical education
India's sex ratio improves, Govt unveils gender-disaggregated data